West Pharmaceutical Services (WST) Raw Materials (2010 - 2012)

West Pharmaceutical Services (WST) has reported Raw Materials for 3 consecutive years, with $68.6 million the latest figure, recorded in Q2 2012.

• Quarterly Raw Materials rose 4.41% year-over-year to $68.6 million in Q2 2012, while the trailing twelve-month figure through Jun 2012 was $68.6 million (up 4.41% YoY) and the FY2011 annual result came in at $65.1 million, up 7.6% from the prior year.
• Raw Materials improved to $68.6 million in Q2 2012 per WST's latest filing, from $65.1 million in the prior quarter.
• Over the last five years, Raw Materials for WST reached as high as $68.6 million in Q2 2012 and fell as low as $60.5 million in Q4 2010.
• A 3-year average of $65.0 million and a median of $65.1 million in 2011 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2011 — Raw Materials grew 7.6% — and 2012, when it climbed 4.41%.
• Year by year, Raw Materials stood at $60.5 million in 2010, then grew by 7.6% to $65.1 million in 2011, then grew by 5.38% to $68.6 million in 2012.
• According to Business Quant data, Raw Materials over the past three periods registered $68.6 million, $65.1 million, and $64.9 million for Q2 2012, Q4 2011, and Q3 2011 respectively.